Connect with us

Newsletters

The Capitalist Newsletter – January 12, 2017

Published

6 years ago

on

Click Here To See The Comments

TRUMP MEETS WITH PRESS FOR FIRST TIME SINCE ELECTION; HERE’S WHAT WE LEARNED

On Wednesday, President-Elect Donald Trump met with the press for the first time since his election victory. In a wild conference, Trump covered Russia, US intelligence agencies, the wall, big pharma, and fake news among other things. While the hour long conference was entertaining to say the least, it also provided a glimpse into Mr. Trump’s plan for the next four to eight years. What can we expect from our 45th president?

Read The Capitalist’s Take Here

Read More at NBC News

Read More at USA Today

SENATORS SLAM TRUMP’S PICK FOR ATTORNEY GENERAL; URGE TO VOTE AGAINST SESSIONS

Washington (CNN)New Jersey Sen. Cory Booker gave an impassioned and unprecedented plea to the Senate on Wednesday to vote against Donald Trump’s nominee for attorney general and his fellow senator, Jeff Sessions. Booker, civil rights legend Georgia Rep. John Lewis and Congressional Black Caucus Chairman Rep. Cedric Richmond each delivered emotional testimony that Sessions’ record on civil rights disqualifies him from serving atop the Justice Department under President-elect Trump.

Read More at CNN Here

Read More at NBC News Here

Read More at Slate Here

SECRETARY OF STATE NOMINEE DECLINES TO PLEDGE U.S. RENEWAL OF RUSSIA SANCTIONS

Rex Tillerson faced an aggressive line of questioning Wednesday from senators about his possible conflicts involving ExxonMobil, his position regarding U.S. sanctions against Russia and his views on climate change. In testimony at his confirmation hearing before the Senate Foreign Relations Committee, Tillerson stressed that the Trump administration is focused on reasserting and renewing U.S. leadership around the world as a superpower, which is an approach that he said the Obama administration has withdrawn from…

Read More at CBS News Here

Read More at CNN Here

Read More at MarketWatch Here

Closing Bell

– Wednesday, January 11th

Financials Lead Markets Higher Despite Healthcare Slide

Big Insider Trades

– Splunk, Inc. (SPLK) Director Godfrey Sullivan Sells $6.75m

-Accelerate Diagnostics, Inc. (AXDX) Director Jack Schuker Buys $6.5m

Winners & Losers

– MYOS RENS Technology, Inc. (MYOS) Skyrockets UP (424.62%) After Amending and Restating Bylaws Following Supreme Court Win

– EnteroMedics, Inc. (ETRM) Falls DOWN (44.77%) After Analysts Downgrade the Company Once Momentum Runs out on 1300% Climb

Most Talked About

MYOS RENS Technology, Inc. (MYOS) a Majority Strong Buy Following its Supreme Court Victory Preventing Insider Trading

The TIP Sheets

– Wednesday, January 11th

– MYOS RENS Technology, Inc. (MYOS) Skyrockets UP (424.62%) After Amending and Restating Bylaws Following Supreme Court Win. The Verdict Prevents Insider Selling of 1.5m Shares of Common Stock. When Combined with the Far Too Fast Rise of the Stock on Wednesday, Expect Shares to Fall Back DOWN

Unusual Volume

– Biocept, Inc. (BIOC) Soars UP (49.72%) on 63m Shares Traded After Picking up Insurance Coverage from BCBS for Its Lead Biopsy Product. Biocept’s Commercial Application of This Technology Means Look for Shares to Continue UP

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Topics:
Continue Reading

Subscribe To Our Newsletter:

CEOJOURNAL.COM | [email protected] | ADDRESS: 1889 E Maule Ave, Ste G, Las Vegas 89119 Copyright © 2021 CEOJournal. his copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.

[email]
[email]